Theoretical investigation of selective ligand binding mode of galanin receptors

@article{Khan2021TheoreticalIO,  title={Theoretical investigation of selective ligand binding mode of galanin receptors},  author={Salman Ali Khan and Komal Zia and Sajda Ashraf and Alamgir Khan and Zaheer Ul-Haq},  journal={Journal of Biomolecular Structure and Dynamics},  year={2021},  volume={40},  pages={12964 - 12974},  url={https://api.semanticscholar.org/CorpusID:238580114}}
Computational modeling characterization strategy was utilized for Galanin receptor 3D structure prediction and subtypes ligands binding selectivity and results indicate key contribution of GalR1 Phe115 and His267 in the selective binding of ligands while Tyr103, Tyr270 and His277 play major role in the selectively binding ofGalR3 ligands.

2 Citations

SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein

SAR, pharmacokinetics, and drug-likeness characteristic investigations showed that kaempferol may be the suitable candidate to serve as a model for designing and developing new anti-COVID-19 medicines.

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor

A comparative interfacial binding pattern of SARS-CoV-2 spike RBD of wild type, Delta, and Omicron with the human ACE2 receptor is explored to determine the crucial determinants at the atomistic level, using MD simulation and MM/GBSA energy calculations.

43 References

Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions

This study presents a mutagenesis study on GalR2 and confer interactions responsible for ligand binding and receptor activation as well as selective recognition of the Gal(2–11) peptide at this receptor subtype.

Galanin receptors as a potential target for neurological disease

The importance of the galanin neurochemical system as a potential target for drug development is highlighted with recent advances and novel approaches in migrating the directions of subtype-selective ligand development and chemical modifications of the peptide backbone highlighted.

The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.

The present review summarizes the information currently available on the relationship between the galaninergic system and known pathological states and the research of novel galanIn receptor specific agonists and antagonists is also very promising for its future role in pharmacological treatment.

Galanin Receptors as Drug Target for Novel Antidepressants: Review

This review addresses the role of GAL, GAL receptors (GALRs), and the mechanism of ligand receptor interaction in attenuating depressive symptoms and suggests that GAL enhances the action of selective serotonin reuptake inhibitors (SSRIs) and promotes availability of transcription proteins.

Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1.

N-terminal carboxylic acid analogues of galanin have low affinity to wild-type GalR1, but substantially increased affinity to the Glu271Lys receptor mutant, which suggests that the N-terminus of Galanin interacts with Phe115.

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.

The present work uses the tripeptidomimetic galnon and displays its presumed pharmacophores on a rigid molecular scaffold and provides an example of a systemically active compound based on a scaffold that mimics protein surfaces.

Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity.

A model of the human GALR1 galanin receptor subtype based on the alpha carbon maps of frog rhodopsin is generated and the significance of potential contact residues suggested by the model using site-directed mutagenesis is investigated.

Galanin and its receptors in neurological disorders

Moderate to low pharmacological effects are seen by galanin under physiological conditions, in contrast to its dramatic effects on the nervous system after neuronal disturbance, which renders it an interest for disorders such as AD, depression, and epilepsy in terms of side effects.

Related Papers

Showing 1 through 3 of 0 Related Papers